CVS Group plc CVSG
LSE · United Kingdom · Health Services
GBp 1,160.00-59.00 (-4.84%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
CVS Group PLC (CVSGF) posted solid full-year revenue and EBITDA growth, expanded in Australia, and signaled confidence in returning to its 4%--8% like-for-like range despite softer consumer footfall.
CVS Group (LON:CVSG) reported full-year revenue growth of 5.9% to £712.8 million and adjusted EBITDA growth of 5.1% to £141.5 million, as all three divisions contributed to growth despite softer market conditions late in the year. Chief Executive Officer Richard Fairman said the company delivered r
CVS Group (LON:CVSG) said revenue for the financial year ended June 30 exceeded GBP 710 million, up 5.9% from the prior year, as the veterinary services provider used an investor presentation to reiterate its capital allocation policy and outline expected returns from acquisitions and capital invest
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.